Dualsystems Biotech AG
Dualsystems Biotech is a service provider for custom proteomics for industry and academia. We are a biotech company specialized in elucidating protein-protein interaction in the living cells especially at the cell membrane. We identify the targets of your extracellular ligands using the ligand-receptor capture LRC-TriCEPS™ technology. For the intracellular signaling we provide the CaptiVate Services using affinity purification/mass spectrometry analysis of protein complexes. Further, we provide Shotgun Proteomics Services for proteins / peptides (LC-MS/MS services) and stable cell line generation for human (HEK, Jurkat), mouse NIH 3T3 and chinese hamster ovary (CHO) cells.
Next generation TriCEPS
TriCEPSTM V.3.0 enables receptor identification for your orphan ligands at the surface of living cells without genetic manipulation.
Key features of the new TriCEPSTM V.3.0 and LRC- TriCEPSTM technology are:
- Less starting material for experiments with rare cell populations:
Ligand receptor capture LRC-TriCEPS™ is a conceptually new technology to analyse the protein interaction of your biologics. We can identify the targets of your protein, antibody and peptide at the cell surface. Dualsystems offers the LRC-TriCEPS™ technology as a service for fee model to the industry and academia (CaptiRec). The technology enables the unbiased identification of cell surface targets and off-targets on the living cells without genetic manipulation. Ligand-receptor capture technology can be used for many types of orphan ligands, such as peptides, proteins, antibodies, engineered affinity binders but also for viruses.
- Extracellular proteins
- Peptide ligands
- Engineered affinity binders
Dualsystems provides the LRC-TriCEPS™ technology al CapitRec Service in a Service for free model.